Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
&NA; Neuropsychiatric disorders are common health problems affecting approximately 1% of the population. Twin, adoption, and family studies have displayed a strong genetic component for many of these disorders; however, the underlying pathophysiological mechanisms and neural substrates remain largely unknown. Given the critical need for new diagnostic markers and disease‐modifying treatments, expanding the focus of genomic studies of neuropsychiatric disorders to include the role of non‐coding RNAs (ncRNAs) is of growing interest. Of known types of ncRNAs, microRNAs (miRNAs) are 20–25‐nucleotide, single‐stranded, molecules that regulate gene expression through post‐transcriptional mechanisms and have the potential to coordinately regulate complex regulatory networks. In this review, we summarize the current knowledge on miRNA alteration/dysregulation in neuropsychiatric disorders, with a special emphasis on schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). With an eye toward the future, we also discuss the diagnostic and prognostic potential of miRNAs for neuropsychiatric disorders in the context of personalized treatments and network medicine. HighlightsMultiple genetic and epigenetic factors have pivotal roles in pathogenesis of neuropsychiatric disorders.MicroRNAs (miRNAs) regulate various physiological processes in the central nervous system at the post‐transcriptional level.Mutations in miRNA genes, and dysregulated miRNA expression are linked to pathogenesis of neuropsychiatric disorders.Deregulated miRNAs may be used for diagnosis, monitoring prognosis and predicting drug response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462 · cited 1×
“1) (Ha and Kim, 2014).”
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · cited 1×
“Electroencephalography (EEG) and magnetoencephalography/electroencephalogram (MEG/EEG) studies supported the disconnection hypothesis (Uhlhaas and Singer, 2010).”
BackgroundFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
The basics of brain development
Stiles, J., & Jernigan, T. L. (2010) · Neuropsychology Review · doi:10.1007/s11065-010-9148-4 · Cited by 2,009 · cited 2×
“…development starts during early stages of embryogenesis, and involves proliferation and differentiation of neurons, migration of immature neurons to their ultimate brain region, outgrowth of axons and dendrites, and generation, as well as proper maintenance, of synapses (Stiles and Jernigan, 2010).”
BackgroundGenome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617 · cited 2×
“This etiology contrasts to rare neuropsychiatric disorders, such as Fragile X syndrome (FMR1) (Fu et al., 1991), Rett syndrome (MECP2) (Amir et al., 1999), and Pitt–Hopkins syndrome (TCF4) (Amiel et al., 2007), where highly penetrant, most often de novo mutations in a single gene are sufficient Laboratory, Departments…”
BackgroundGenome-wide association analysis identifies 13 new risk loci for schizophrenia
Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496 · cited 2×
“…in the upstream region of the host gene for miR-137 have been strongly associated with SCZ (Cummings et al., 2013; Green et al., 2013; Psychosis Endophenotypes International et al., 2014; Ripke et al., 2013; Schizophrenia Psychiatric Genome-Wide Association Study, 2011; Whalley et al., 2012).”
Normal development of brain circuits
Tau, G. Z., & Peterson, B. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.115 · Cited by 1,391
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Self-citationRegressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316 · cited 2×
“Combination of lithium and VPA has been also tested in vitro, which leads to a decrease in miR-30a-5p in SH-SY5Y human neuron-like cells (Croce et al., 2014).”
BackgroundWellcome Trust Case Control Consortium, Ferreira, M. A. R., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.209 · Cited by 1,237 · cited 1×
“Notably, miR-185 is located on this locus, and the role of this miRNA and its downstream pathways has also been implicated in SCZ (Brzustowicz and Bassett, 2012; Forstner et al., 2013; Gardiner et al., 2012).”
BackgroundGenetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · cited 2×
“…(Network & Pathway Analysis Subgroup of Psychiatric Genomics, 2015; Schizophrenia Working Group of the Psychiatric Genomics, 2014), although further studies are required to unambiguously elucidate causal genetic factors in each locus [reviewed in (Sullivan et al., 2012; Kotlar et al., 2015)].”
BackgroundDysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134 · cited 1×
“Additionally, functional neuroimaging studies have found reduced frontotemporal connectivity by functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) (Stephan et al., 2009).”
BackgroundKirov, G., Pocklington, A. J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.154 · Cited by 844
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755 · cited 1×
“The contributor mechanisms of specific enrichment of miRNAs within synapses, dendrites, and axons remain unknown, but involvement of some RNA-binding proteins for delivering or anchoring miRNAs to particular neuron areas is possible (O'Carroll and Schaefer, 2013).”
BackgroundRegulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C.-F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A., & Sheng, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.005 · Cited by 735
Regulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707 · cited 2×
“Another brain-specific miRNA is miR-9, which is expressed in both neurons and glia. miR-9 plays an essential role in various aspects of neurogenesis (Smirnova et al., 2005).”
BackgroundPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
Miller, D. T., Shen, Y., Weiss, L. A., Korn, J., Anselm, I., Bridgemohan, C., Cox, G. F., Dickinson, H., Gentile, J., Harris, D. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059907 · Cited by 427
DNA methylation of BDNF as a biomarker of early-life adversity
Kundakovic, M., Gudsnuk, K., Herbstman, J. B., Tang, D., Perera, F. P., & Champagne, F. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408355111 · Cited by 426
Genome-wide association study reveals two new risk loci for bipolar disorder
Mühleisen, T. W., Leber, M., Schulze, T. G., Strohmaier, J., Degenhardt, F., Treutlein, J., Mattheisen, M., Forstner, A. J., Schumacher, J., Breuer, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4339 · Cited by 346
Epigenetic basis of mental illness
Nestler, E. J., Peña, C. J., Kundakovic, M., Mitchell, A., & Akbarian, S. (2016) · The Neuroscientist · doi:10.1177/1073858415608147 · Cited by 342
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324 · cited 5×
“In contrast, no associationwas observed between themRNA levels of Dicer, Drosha and DGCR8; but this finding is based on data from small subset of MDD patients and control subjects (Smalheiser et al., 2012).”
BackgroundResultInfluentialAmiel, J., Rio, M., Pontual, L. D., Redon, R., Malan, V., Boddaert, N., Plouin, P., Carter, N. P., Lyonnet, S., Munnich, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/515582 · Cited by 319
Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P. J., Elsworth, J. D., Lawrence, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113793109 · Cited by 309
Lopez, J. P., Lim, R., Cruceanu, C., Crapper, L., Fasano, C., Labonte, B., Maussion, G., Yang, J. P., Yerko, V., Vigneault, E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3582 · Cited by 308 · cited 2×
“Lopez et al. (2014b) Downregulation: miR-1202 Postmortem tissue — PFC (BA44) Real-time PCR 16 suicide completers (all MDD patients) 15 control subjects Authors quantified the expression levels of the predicted gene targets of miR-1202 and upregulation in the level of metabotropic glutamate receptor…”
BackgroundKim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298 · cited 10×
“…brain tissues from SCZ patients are used, and a vast number of differentially expressed miRNAs have been identified (Banigan et al., 2013; Beveridge et al., 2008, 2010; Kim et al., 2010; Levinson et al., 2014; Perkins et al., 2007; Santarelli et al., 2013; Wong et al., 2013; Zhu et al., 2009).”
BackgroundResultInfluentialMoreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.039 · Cited by 279
Liu, C., Zhang, F., Li, T., Lu, M., Wang, L., Yue, W., & Zhang, D. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-661 · Cited by 264 · cited 2×
“Other SNP findings associated with SCZ are located in predicted binding site of miR-625 and miR-1302 in purinergic receptor P2X (P2RX7) gene, in the miR-124 binding site of regulator of G protein signaling 4 (RGS4) gene (rs10759); and 3 other SNPs (rs17110432, rs11178988 and rs11178989) in the 3′-UTR of TBC1 domain fa…”
BackgroundBlood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238
Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage
Kochunov, P., & Hong, L. E. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu070 · Cited by 236
MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
Lai, C.-Y., Yu, S.-L., Hsieh, M. H., Chen, C.-H., Chen, H.-Y., Wen, C.-C., Huang, Y.-H., Hsiao, P.-C., Hsiao, C. K., Liu, C.-M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021635 · Cited by 228 · cited 4×
“Lai et al. (2011) Down-regulation: miR-432 Up-regulation: miR-34a, miR-449a, miR-548d, miR-564, miR-572, miR-652 Blood — WBCs TaqMan low density array v.1.0 30 SCZ patients, 30 control subjects Not assessed Shi et al. (2012) Down-regulation: miR-195 Up-regulation: let-7g, miR-181b, miR-219-2-3p,…”
BackgroundInfluentialAn updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
Dopamine-Regulated MicroRNA MiR-181a Controls GluA2 Surface Expression in Hippocampal Neurons
Saba, R., Störchel, P. H., Aksoy-Aksel, A., Kepura, F., Lippi, G., Plant, T. D., & Schratt, G. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05896-11 · Cited by 219 · cited 1×
“It can regulate the glutamate receptor 2 subunit (GluA2) of AMPA receptors, which are vitally involved in synaptic plasticity, at the post-transcriptional level (Saba et al., 2012).”
BackgroundGeneral Principals of miRNA Biogenesis and Regulation in the Brain
O'Carroll, D., & Schaefer, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.87 · Cited by 205
Fénelon, K., Mukai, J., Xu, B., Hsu, P.-K., Drew, L. J., Karayiorgou, M., Fischbach, G. D., MacDermott, A. B., & Gogos, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101219108 · Cited by 202
Wan, Y., Liu, Y., Wang, X., Wu, J., Liu, K., Zhou, J., Liu, L., & Zhang, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121975 · Cited by 182 · cited 3×
“(Wan et al., 2015).”
BackgroundSaus, E., Soria, V., Escaramís, G., Vivarelli, F., Crespo, J. M., Kagerbauer, B., Menchón, J. M., Urretavizcaya, M., Gratacòs, M., & Estivill, X. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq316 · Cited by 163 · cited 1×
“Finally, 2 SNPs in pre-miR-182 (rs76481776) and pre-miR-30e (ss178077483) are associated with MDD (Saus et al., 2010; Xu et al., 2010).”
BackgroundLevinson, D. F., Mostafavi, S., Milaneschi, Y., Rivera, M., Ripke, S., Wray, N. R., & Sullivan, P. F. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.029 · Cited by 159 · cited 2×
“…brain tissues from SCZ patients are used, and a vast number of differentially expressed miRNAs have been identified (Banigan et al., 2013; Beveridge et al., 2008, 2010; Kim et al., 2010; Levinson et al., 2014; Perkins et al., 2007; Santarelli et al., 2013; Wong et al., 2013; Zhu et al., 2009).”
BackgroundLopez, J. P., Fiori, L. M., Gross, J. A., Labonte, B., Yerko, V., Mechawar, N., & Turecki, G. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000941 · Cited by 103 · cited 2×
“Lopez et al. (2014b) Downregulation: miR-1202 Postmortem tissue — PFC (BA44) Real-time PCR 16 suicide completers (all MDD patients) 15 control subjects Authors quantified the expression levels of the predicted gene targets of miR-1202 and upregulation in the level of metabotropic glutamate receptor…”
BackgroundRuzicka, W. B., Subburaju, S., & Benes, F. M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.49 · Cited by 101 · cited 2×
“Target genes of abnormal DNA methylation are common SCZ and BD. HLA9 and GAD1 gene methylation changes were observed in the brain tissue of patients with BD (Kaminsky et al., 2012; Ruzicka et al., 2015).”
BackgroundMaussion, G., Yang, J., Yerko, V., Barker, P., Mechawar, N., Ernst, C., & Turecki, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039301 · Cited by 91
Molecular Profiles of Pyramidal Neurons in the Superior Temporal Cortex in Schizophrenia
Pietersen, C. Y., Mauney, S. A., Kim, S. S., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., McCarley, R. W., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2014.882918 · Cited by 87
MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4
Li, J., Meng, H., Cao, W., & Qiu, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.038 · Cited by 73
Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients
Yu, H.-C., Wu, J., Zhang, H.-X., Zhang, G.-L., Sui, J., Tong, W.-W., Zhang, X.-Y., Nie, L.-L., Duan, J.-H., Zhang, L.-R., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.007 · Cited by 71
Yang, X., Yang, Q., Wang, X., Luo, C., Wan, Y., Li, J., Liu, K., Zhou, M., & Zhang, C. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8312-z · Cited by 69
Oved, K., Morag, A., Pasmanik-Chor, M., Oron-Karni, V., Shomron, N., Rehavi, M., Stingl, J. C., & Gurwitz, D. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.93 · Cited by 66
Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms
Halmai, Z., Dome, P., Vereczkei, A., Abdul-Rahman, O., Szekely, A., Gonda, X., Faludi, G., Sasvari-Szekely, M., & Nemoda, Z. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.033 · Cited by 55
Genetic Variations in MicroRNA Processing Genes Are Associated with Susceptibility in Depression
He, Y., Zhou, Y., Xi, Q., Cui, H., Luo, T., Song, H., Nie, X., Wang, L., & Ying, B. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1660 · Cited by 52 · cited 1×
“2): (1) in themachinery genes related tomiRNA biogenesis; (2) in the miRNA promoter sequences; (3) in the sequences responsible for pre-miRNA cleavage; (4) the miRNA binding sites in target genes; or (5) in the seed sequences (Hogg and Harries, 2014).”
BackgroundWong, J., Duncan, C. E., Beveridge, N. J., Webster, M. J., Cairns, M. J., & Shannon Weickert, C. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr177 · Cited by 43
EGR3 as a potential susceptibility gene for schizophrenia in Korea
Kim, S. H., Song, J. Y., Joo, E., Lee, K. Y., Ahn, Y. M., & Kim, Y. S. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31115 · Cited by 41 · cited 6×
“…brain tissues from SCZ patients are used, and a vast number of differentially expressed miRNAs have been identified (Banigan et al., 2013; Beveridge et al., 2008, 2010; Kim et al., 2010; Levinson et al., 2014; Perkins et al., 2007; Santarelli et al., 2013; Wong et al., 2013; Zhu et al., 2009).”
BackgroundResultInfluentialAnalysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene
Rahman, O. A., Sasvari‐Szekely, M., Szekely, A., Faludi, G., Guttman, A., & Nemoda, Z. (2010) · ELECTROPHORESIS · doi:10.1002/elps.200900664 · Cited by 28
The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders
Jensen, K. P., Kranzler, H. R., Stein, M. B., & Gelernter, J. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32219 · Cited by 25 · cited 2×
“…analysis of 609 autosomal miRNAs was performed in the Table 1 (continued) MiRNA Population Number of samples Functional result (rs1653625) Jensen et al. (2014) SNPs: Predicted binding site of miR-330-3p in MAP2K5 gene; only significant in African Americans (rs41305272) European…”
Background
Cited by
The microbiome regulates amygdala-dependent fear recall
Hoban, A. E., Stilling, R. M., Moloney, G., Shanahan, F., Dinan, T. G., Clarke, G., & Cryan, J. F. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.100 · Cited by 197
Microbial regulation of microRNA expression in the amygdala and prefrontal cortex
Hoban, A. E., Stilling, R. M., M. Moloney, G., Moloney, R. D., Shanahan, F., Dinan, T. G., Cryan, J. F., & Clarke, G. (2017) · Microbiome · doi:10.1186/s40168-017-0321-3 · Cited by 177
Soto-Angona, Ó., Anmella, G., Valdés-Florido, M. J., De Uribe-Viloria, N., Carvalho, A. F., Penninx, B. W. J. H., & Berk, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01713-8 · Cited by 122
“An increasing body of evidence is delving into their role in psychiatric disorders [61].”
BackgroundGruzdev, S. K., Yakovlev, A. A., Druzhkova, T. A., Guekht, A. B., & Gulyaeva, N. V. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00684-6 · Cited by 75
Kahl, K. G., Stapel, B., & Frieling, H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.004 · Cited by 47
Metadata
- Authors
- Alural, B., Genc, S., & Haggarty, S. J.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 73
- Pages
- 87-103
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2314196082
- Cited by
- 72
- References
- 57
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.